Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Køge Hospital Project Team I/S Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading... Loading... Loading... Loading...

1.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 4.2% 4.2%   Bankruptcy risk   5.2% 4.8% 5.8% 5.6% 6.2% 1.8% 7.0% 7.0%   Credit score (0-100)   44 46 40 39 37 70 34 34   Credit rating   BBB BBB BBB BBB BBB A BBB BBB   Credit limit (mDKK)   0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1.0 Income statement (mDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   41 100 223 403 457 389 389 389   Gross profit   4.7 100 223 403 80.6 134 0.0 0.0   EBITDA   2.0 100 223 403 -14.0 39.8 0.0 0.0   EBIT   2.0 100 223 403 -22.0 31.4 0.0 0.0   Pre-tax profit (PTP)   2.0 0.0 0.0 0.0 -22.3 31.6 0.0 0.0   Net earnings   2.0 0.0 0.0 0.0 -22.3 31.6 0.0 0.0   Pre-tax profit without non-rec. items   2.0 100 223 403 -22.3 31.6 0.0 0.0     See the entire income statement 1.0 Balance sheet (mDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   0.0 0.0 0.0 0.0 15.8 17.0 0.0 0.0   Shareholders equity total   2.0 4.2 11.0 22.4 0.1 31.7 31.7 31.7   Interest-bearing liabilities   4.5 0.0 0.0 0.0 2.6 2.1 0.0 0.0   Balance sheet total (assets)   21.4 157 154 182 208 292 31.7 31.7   Net Debt   -1.5 0.0 0.0 0.0 -6.5 -53.5 -31.7 -31.7     See the entire balance sheet 1.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   41 100 223 403 457 389 389 389   Net sales growth   0.0% 146.1% 122.2% 80.3% 13.5% -15.0% 0.0% 0.0%   Gross profit   4.7 100 223 403 80.6 134 0.0 0.0   Gross profit growth   0.0% 2,018.5% 122.2% 80.3% -80.0% 66.5% -100.0% 0.0%   Employees   13 19 44 79 141 103 0 0   Employee growth %   0.0% 46.2% 131.6% 79.5% 78.5% -27.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   21 157 154 182 208 292 32 32   Balance sheet change%   0.0% 632.1% -1.6% 18.1% 14.1% 40.6% -89.1% 0.0%   Added value   2.0 100.4 223.2 402.5 -22.0 39.8 0.0 0.0   Added value %   5.0% 100.0% 100.0% 100.0% -4.8% 10.2% 0.0% 0.0%   Investments   0 0 0 0 8 -7 -17 0   Net sales trend   0.0 1.0 2.0 3.0 4.0 -1.0 0.0 0.0   EBIT trend   1.0 2.0 3.0 4.0 -1.0 1.0 0.0 0.0   1.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   5.0% 100.0% 100.0% 100.0% -3.1% 10.2% 0.0% 0.0%   EBIT %   5.0% 100.0% 100.0% 100.0% -4.8% 8.1% 0.0% 0.0%   EBIT to gross profit (%)   43.0% 100.0% 100.0% 100.0% -27.2% 23.4% 0.0% 0.0%   Net Earnings %   5.0% 0.0% 0.0% 0.0% -4.9% 8.1% 0.0% 0.0%   Profit before depreciation and extraordinary items %   5.0% 0.0% 0.0% 0.0% -3.1% 10.3% 0.0% 0.0%   Pre tax profit less extraordinaries %   5.0% 100.0% 100.0% 100.0% -4.9% 8.1% 0.0% 0.0%   ROA %   9.7% 112.8% 143.6% 239.5% -11.2% 12.8% 0.0% 0.0%   ROI %   31.8% 123.1% 143.6% 239.5% -23.2% 140.6% 0.0% 0.0%   ROE %   100.0% 0.0% 0.0% 0.0% -198.1% 198.7% 0.0% 0.0%   1.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   9.5% 100.0% 100.0% 100.0% 0.1% 12.6% 100.0% 100.0%   Relative indebtedness %   47.5% 0.0% 0.0% 0.0% 28.2% 50.6% 0.0% 0.0%   Relative net indebtedness %   32.7% 0.0% 0.0% 0.0% 26.2% 36.3% -8.2% -8.2%   Net int. bear. debt to EBITDA, %   -74.2% 0.0% 0.0% 0.0% 46.3% -134.4% 0.0% 0.0%   Gearing %   222.0% 0.0% 0.0% 0.0% 2,485.1% 6.6% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   2.2% 0.0% 0.0% 0.0% 29.5% 12.0% 0.0% 0.0%   1.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   1.1 0.0 0.0 0.0 2.1 1.6 0.0 0.0   Current Ratio   1.1 0.0 0.0 0.0 1.5 1.4 0.0 0.0   Cash and cash equivalent   6.0 0.0 0.0 0.0 9.1 55.6 0.0 0.0   1.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   33.5 0.0 0.0 0.0 51.0 85.7 0.0 0.0   Trade creditors turnover (days)   147.3 0.0 0.0 0.0 51.6 184.7 0.0 0.0   Current assets / Net sales %   52.4% 0.0% 0.0% 0.0% 42.0% 70.8% 8.2% 8.2%   Net working capital   2.0 0.0 0.0 0.0 66.9 83.2 0.0 0.0   Net working capital %   5.0% 0.0% 0.0% 0.0% 14.6% 21.4% 0.0% 0.0%   1.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   3 5 5 5 3 4 0 0   Added value / employee   0 5 5 5 -0 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 5 5 5 -0 0 0 0   EBIT / employee   0 5 5 5 -0 0 0 0   Net earnings / employee   0 0 0 0 -0 0 0 0